单位(元)广发创新药ETF(515120)资产负债表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
资产 |
银行存款 |
12,821,786 |
24,680,529 |
6,299,270 |
9,866,743 |
结算备付金 |
2,714,571 |
911,741 |
1,387,178 |
806,294 |
存出保证金 |
715,840 |
1,110,245 |
433,509 |
421,814 |
交易性金融资产 |
4,099,963,075 |
3,193,926,646 |
1,676,705,809 |
1,429,651,600 |
其中:股票投资 |
4,099,963,075 |
3,193,926,646 |
1,676,705,809 |
1,429,651,600 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
621,068 |
4,138,714 |
- |
7,717,693 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
113,220 |
- |
5,370 |
应收申购款 |
- |
- |
- |
- |
其他资产 |
174,137 |
155,099 |
112,273 |
90,377 |
资产总计 |
4,117,010,477 |
3,225,036,195 |
1,684,938,039 |
1,448,559,891 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
3,030,569 |
531,721 |
6,790,990 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
1,751,056 |
1,327,963 |
721,436 |
558,608 |
应付托管费 |
350,211 |
265,593 |
144,287 |
111,722 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
20,522 |
17,678 |
12,839 |
1,296 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
7,670,140 |
3,719,884 |
2,083,552 |
2,368,321 |
负债合计 |
9,791,930 |
8,361,687 |
3,493,836 |
9,830,937 |
所有者权益 |
实收基金 |
6,657,993,564 |
5,256,993,564 |
2,420,993,564 |
1,809,993,564 |
未分配利润 |
-2,550,775,017 |
-2,040,319,056 |
-739,549,361 |
-371,264,609 |
所有者权益合计 |
4,107,218,547 |
3,216,674,508 |
1,681,444,203 |
1,438,728,955 |
负债和所有者权益总计 |
4,117,010,477 |
3,225,036,195 |
1,684,938,039 |
1,448,559,891 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。